BZYR: Burzynski Research Institute, Inc. Stock

by  •  • Comments Off on BZYR: Burzynski Research Institute, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 5.65
Enterprise Value ($M) 5.65
Book Value ($M) -0.04
Book Value / Share -0.00
Price / Book -135.75
NCAV ($M) -0.04
NCAV / Share -0.00
Price / NCAV -135.75

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -600.09
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.02
Current Ratio 0.02

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.04
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -1.39
Net Income -1.39
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -0.39
Cash from Investing 0.00
Cash from Financing 0.39

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2025-01-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-10-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-07-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)

Similar Companies
BSPK – Bespoke Extracts, Inc. BSPM – Biostar Pharmaceuticals, Inc.
BTAX – Biostax Corp. CALA – Calithera Biosciences, Inc.
CBDL – CBD Life Sciences Inc.


Financial data and stock pages provided by
Fintel.io